131 – 140 of 3522
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Diffuse fluorescence tomography for photodynamic therapy of tumors
Šušnjar, Stefan LU
; Ghauri, Daniyal
; Thomasson, Björn
; Sekar, Sanathana Konugolu Venkata
; Andersson-Engels, Stefan
; Swartling, Johannes
and Reistad, Nina
LU
(2025)
SPIE Photonics West 2025
13320.
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Characterisation of heritable TP53-related cancer syndrome in Sweden—a nationwide study of genotype-phenotype correlations in 90 families
- Contribution to journal › Article
-
Mark
Prediction of survival after pancreatoduodenectomy for distal cholangiocarcinoma : independent external validation of a prognostic model for 3-year overall survival in Sweden
Byrling, Johannes LU and Andersson, Bodil LU
(2025)
In Scandinavian Journal of Gastroenterology
60(2).
p.158-164
- Contribution to journal › Article
-
Mark
Impact of smoking status on engagement in remote symptom monitoring after oncologic surgery : Implications for symptom management and readmission rates
- Contribution to journal › Article
-
Mark
Healthcare Professionals’ Ratings and Views of Person-Centred Care in the Context of Allogeneic Hematopoietic Stem Cell Transplantation
O’Sullivan, Anna ; Winterling, Jeanette ; Malmborg Kisch, Annika LU
; Bergkvist, Karin
; Edvardsson, David
; Wengström, Yvonne
and Lundh Hagelin, Carina
LU
(2025)
In Health Services Insights
18.
- Contribution to journal › Article
-
Mark
Metabolic syndrome is associated with breast cancer mortality : A systematic review and meta-analysis
- Contribution to journal › Article
-
Mark
Reply to Laila Schneidewind, Fabian P. Stangl, Jennifer Kranz, and Gernot Bonkat's Letter to Editor re : Fredrik Liedberg, Evanguelos Xylinas, Paolo Gontero. Quinolone Prophylaxis in Conjunction with Bacillus Calmette-Guérin Instillations for Bladder Cancer: Time To Reconsider the Evidence and Open the Quinolone Box? Eur Urol Focus 2024;10:564–6
- Contribution to journal › Debate/Note/Editorial
-
Mark
Lymphomas : ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
- Contribution to journal › Article
-
Mark
Observational Health Data Analysis of the Cardiovascular Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer : Big Data Analytics Using the PIONEER Platform
- Contribution to journal › Article
-
Mark
A Systematic Review and Meta-analysis of the Clinical Impact of Prophylactic Quinolones with Adjuvant Bacillus Calmette-Guérin Instillation for Non-muscle-invasive Bladder Cancer
- Contribution to journal › Article